Recurrent WHO Grade 3 Glioma Clinical Trials

3 clinical trials for Recurrent WHO Grade 3 Glioma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment — RECRUITING · PHASE2
• Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas — RECRUITING · PHASE1
• Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma — RECRUITING · PHASE1

Refine this search